Hubei Jumpcan Pharmaceutical Co Ltd operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Hubei Jumpcan Pharmaceutical Co Ltd with three other
companies in this sector in China:
KPC Pharmaceuticals Inc
sales of 7.10 billion Chinese Renmimbi [US$1.03 billion]
of which 39%
was Drugs Wholesale and Retail),
Northeast Pharmaceutical Group Co., Ltd.
(7.47 billion Chinese Renmimbi [US$1.09 billion]
of which 71%
was Pharmaceutical Products), and
Dong-E-E-Jiao Co Ltd
(7.34 billion Chinese Renmimbi [US$1.07 billion]
of which 86%
was E-Jiao and Series Products).
Hubei Jumpcan Pharmaceutical Co Ltd reported sales of 7.21 billion Chinese Renmimbi (US$1.05 billion)
December of 2018.
increase of 27.8%
versus 2017, when the company's sales were 5.64 billion Chinese Renmimbi.
Sales at Hubei Jumpcan Pharmaceutical Co Ltd have increased during each of the previous five years
(and since 2013, sales have increased a total of 195%).
Sales of Industrial saw an increase
28.5% in 2018, from
5.43 billion Chinese Renmimbi to 6.97 billion Chinese Renmimbi.